Dean Y. Li, Director at RECURSION PHARMACEUTICALS, INC. (RXRX), sold 57,038 shares at $13.65 ($779K) on 2024-01-09, disclosed to the SEC on 2024-01-11.
Scheduled sale ($779k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.65 | 28,038 | $383K | 49.1% |
| 2 | $13.65 | 28,038 | $383K | 49.1% |
| 3 | $14.03 | 962 | $13K | 1.7% |
| Total | $13.66 avg | 57,038 | $779K | 100% |
| Filing → |
| MRK | SELL | 2024-02-12 | $1.8M | — | Filing → |
| RXRX | SELL | 2021-12-09 | $770K | — | Filing → |
| RXRX | SELL | 2021-12-09 | $326K | — | Filing → |